Cargando…
N,N-Diethyl-4-[1-phenyl-3-(pyridin-2-yl)-4,5-dihydro-1H-pyrazol-5-yl]aniline
In the title molecule, C(24)H(26)N(4), the pyrazoline ring assumes an envelope conformation with the aniline-bearing C atom at the flap position. The benzene ring and the pyridine ring form with the pyrazoline ring dihedral angles of 4.53 (1) and 6.26 (1)°, respectively. In turn, the aniline group...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Union of Crystallography
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3793803/ https://www.ncbi.nlm.nih.gov/pubmed/24109390 http://dx.doi.org/10.1107/S1600536813019879 |
_version_ | 1782287121887789056 |
---|---|
author | Zhu, Ying-Zhong Wang, Hui Sun, Ping-Ping Tian, Yu-Peng |
author_facet | Zhu, Ying-Zhong Wang, Hui Sun, Ping-Ping Tian, Yu-Peng |
author_sort | Zhu, Ying-Zhong |
collection | PubMed |
description | In the title molecule, C(24)H(26)N(4), the pyrazoline ring assumes an envelope conformation with the aniline-bearing C atom at the flap position. The benzene ring and the pyridine ring form with the pyrazoline ring dihedral angles of 4.53 (1) and 6.26 (1)°, respectively. In turn, the aniline group is nearly perpendicular to the pyrazoline ring [dihedral angle = 79.96 (1)°]. The ethyl groups of the diethylamine substituent are disordered over two sets of sites, with an occupancy ratio of 0.624 (8):0.376 (8). |
format | Online Article Text |
id | pubmed-3793803 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | International Union of Crystallography |
record_format | MEDLINE/PubMed |
spelling | pubmed-37938032013-10-09 N,N-Diethyl-4-[1-phenyl-3-(pyridin-2-yl)-4,5-dihydro-1H-pyrazol-5-yl]aniline Zhu, Ying-Zhong Wang, Hui Sun, Ping-Ping Tian, Yu-Peng Acta Crystallogr Sect E Struct Rep Online Organic Papers In the title molecule, C(24)H(26)N(4), the pyrazoline ring assumes an envelope conformation with the aniline-bearing C atom at the flap position. The benzene ring and the pyridine ring form with the pyrazoline ring dihedral angles of 4.53 (1) and 6.26 (1)°, respectively. In turn, the aniline group is nearly perpendicular to the pyrazoline ring [dihedral angle = 79.96 (1)°]. The ethyl groups of the diethylamine substituent are disordered over two sets of sites, with an occupancy ratio of 0.624 (8):0.376 (8). International Union of Crystallography 2013-07-27 /pmc/articles/PMC3793803/ /pubmed/24109390 http://dx.doi.org/10.1107/S1600536813019879 Text en © Zhu et al. 2013 http://creativecommons.org/licenses/by/2.0/uk/ This is an open-access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original authors and source are cited. |
spellingShingle | Organic Papers Zhu, Ying-Zhong Wang, Hui Sun, Ping-Ping Tian, Yu-Peng N,N-Diethyl-4-[1-phenyl-3-(pyridin-2-yl)-4,5-dihydro-1H-pyrazol-5-yl]aniline |
title |
N,N-Diethyl-4-[1-phenyl-3-(pyridin-2-yl)-4,5-dihydro-1H-pyrazol-5-yl]aniline |
title_full |
N,N-Diethyl-4-[1-phenyl-3-(pyridin-2-yl)-4,5-dihydro-1H-pyrazol-5-yl]aniline |
title_fullStr |
N,N-Diethyl-4-[1-phenyl-3-(pyridin-2-yl)-4,5-dihydro-1H-pyrazol-5-yl]aniline |
title_full_unstemmed |
N,N-Diethyl-4-[1-phenyl-3-(pyridin-2-yl)-4,5-dihydro-1H-pyrazol-5-yl]aniline |
title_short |
N,N-Diethyl-4-[1-phenyl-3-(pyridin-2-yl)-4,5-dihydro-1H-pyrazol-5-yl]aniline |
title_sort | n,n-diethyl-4-[1-phenyl-3-(pyridin-2-yl)-4,5-dihydro-1h-pyrazol-5-yl]aniline |
topic | Organic Papers |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3793803/ https://www.ncbi.nlm.nih.gov/pubmed/24109390 http://dx.doi.org/10.1107/S1600536813019879 |
work_keys_str_mv | AT zhuyingzhong nndiethyl41phenyl3pyridin2yl45dihydro1hpyrazol5ylaniline AT wanghui nndiethyl41phenyl3pyridin2yl45dihydro1hpyrazol5ylaniline AT sunpingping nndiethyl41phenyl3pyridin2yl45dihydro1hpyrazol5ylaniline AT tianyupeng nndiethyl41phenyl3pyridin2yl45dihydro1hpyrazol5ylaniline |